Correlation Between PsyBio Therapeutics and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both PsyBio Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PsyBio Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PsyBio Therapeutics Corp and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on PsyBio Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PsyBio Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PsyBio Therapeutics and Reviva Pharmaceuticals.

Diversification Opportunities for PsyBio Therapeutics and Reviva Pharmaceuticals

0.0

Correlation Coefficient

PsyBio Therapeutics  Reviva Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between PsyBio and Reviva is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PsyBio Therapeutics Corp and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and PsyBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PsyBio Therapeutics Corp are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of PsyBio Therapeutics i.e., PsyBio Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between PsyBio Therapeutics and Reviva Pharmaceuticals

Assuming the 90 days horizon PsyBio Therapeutics Corp is expected to generate 6.93 times more return on investment than Reviva Pharmaceuticals. However, PsyBio Therapeutics is 6.93 times more volatile than Reviva Pharmaceuticals Holdings. It trades about 0.05 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.0 per unit of risk. If you would invest  1.47  in PsyBio Therapeutics Corp on December 5, 2024 and sell it today you would lose (1.46) from holding PsyBio Therapeutics Corp or give up 99.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.74%
Values	Daily Returns

PsyBio Therapeutics Corp  vs.  Reviva Pharmaceuticals Holding

PsyBio Therapeutics Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days PsyBio Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, PsyBio Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Reviva Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Reviva Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with PsyBio Therapeutics and Reviva Pharmaceuticals

The main advantage of trading using opposite PsyBio Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PsyBio Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind PsyBio Therapeutics Corp and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.